Psychopathology and quality of life burden in chronic daily headache: influence of migraine symptoms
- PMID: 20383733
- PMCID: PMC3451907
- DOI: 10.1007/s10194-010-0208-1
Psychopathology and quality of life burden in chronic daily headache: influence of migraine symptoms
Abstract
The aim of this study is to compare the psychopathology and the quality of life of chronic daily headache patients between those with migraine headache and those with tension-type headache. We enrolled 106 adults with chronic daily headache (CDH) who consulted for the first time in specialised centres. The patients were classified according to the IHS 2004 criteria and the propositions of the Headache Classification Committee (2006) with a computed algorithm: 8 had chronic migraine (without medication overuse), 18 had chronic tension-type headache (without medication overuse), 80 had medication overuse headache and among them, 43 fulfilled the criteria for the sub-group of migraine (m) MOH, and 37 the subgroup for tension-type (tt) MOH. We tested five variables: MADRS global score, HAMA psychic and somatic sub-scales, SF-36 psychic, and somatic summary components. We compared patients with migraine symptoms (CM and mMOH) to those with tension-type symptoms (CTTH and ttMOH) and neutralised pain intensity with an ANCOVA which is a priori higher in the migraine group. We failed to find any difference between migraine and tension-type groups in the MADRS global score, the HAMA psychological sub-score and the SF36 physical component summary. The HAMA somatic anxiety subscale was higher in the migraine group than in the tension-type group (F(1,103) = 10.10, p = 0.001). The SF36 mental component summary was significantly worse in the migraine as compared with the tension-type subgroup (F(1,103) = 5.758, p = 0.018). In the four CDH subgroups, all the SF36 dimension scores except one (Physical Functioning) showed a more than 20 point difference from those seen in the adjusted historical controls. Furthermore, two sub-scores were significantly more affected in the migraine group as compared to the tension-type group, the physical health bodily pain (F(1,103) = 4.51, p = 0.036) and the mental health (F(1,103) = 8.17, p = 0.005). Considering that the statistic procedure neutralises the pain intensity factor, our data suggest a particular vulnerability to somatic symptoms and a special predisposition to develop negative pain affect in migraine patients in comparison to tension-type patients.
Similar articles
-
Evaluation of Risk Factors in Patients With Chronic Daily Headache and Medication-Overuse Headache.Brain Behav. 2025 Mar;15(3):e70407. doi: 10.1002/brb3.70407. Brain Behav. 2025. PMID: 40079498 Free PMC article.
-
Prevalence and burden of headache in children and adolescents in Austria - a nationwide study in a representative sample of pupils aged 10-18 years.J Headache Pain. 2019 Nov 6;20(1):101. doi: 10.1186/s10194-019-1050-8. J Headache Pain. 2019. PMID: 31694547 Free PMC article.
-
Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache.Eur J Pain. 2005 Jun;9(3):285-91. doi: 10.1016/j.ejpain.2004.07.006. Eur J Pain. 2005. PMID: 15862478
-
The epidemiology of primary headache disorders.Semin Neurol. 2010 Apr;30(2):107-19. doi: 10.1055/s-0030-1249220. Epub 2010 Mar 29. Semin Neurol. 2010. PMID: 20352581 Review.
-
Myofascial trigger points in migraine and tension-type headache.J Headache Pain. 2018 Sep 10;19(1):84. doi: 10.1186/s10194-018-0913-8. J Headache Pain. 2018. PMID: 30203398 Free PMC article. Review.
Cited by
-
Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache.J Headache Pain. 2012 Jun;13(4):281-90. doi: 10.1007/s10194-012-0432-y. Epub 2012 Mar 17. J Headache Pain. 2012. PMID: 22427000 Free PMC article.
-
Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine.Cephalalgia. 2022 Sep;42(10):1005-1012. doi: 10.1177/03331024221089567. Epub 2022 Mar 25. Cephalalgia. 2022. PMID: 35332807 Free PMC article. Clinical Trial.
-
Evaluation of Risk Factors in Patients With Chronic Daily Headache and Medication-Overuse Headache.Brain Behav. 2025 Mar;15(3):e70407. doi: 10.1002/brb3.70407. Brain Behav. 2025. PMID: 40079498 Free PMC article.
-
Chronic migraine classification: current knowledge and future perspectives.J Headache Pain. 2011 Dec;12(6):585-92. doi: 10.1007/s10194-011-0393-6. Epub 2011 Oct 26. J Headache Pain. 2011. PMID: 22028184 Free PMC article. Review.
-
Complementary and conventional medicine use among youth with recurrent headaches.Pediatrics. 2013 Nov;132(5):e1173-83. doi: 10.1542/peds.2013-1816. Epub 2013 Oct 14. Pediatrics. 2013. PMID: 24127466 Free PMC article.
References
-
- Wang SJ, Fuh JL, Lu SR, Liu CY, Hsu LC, Wang PN, Liu HC. Chronic daily headache in Chinese elderly. Prevalence, risk factors, and biannual follow-up. Neurology. 2000;54:314–319. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical